Screener
Agios Pharmaceuticals AGIO Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's gross margin?
- Agios Pharmaceuticals (AGIO) reported gross margin of 92% in Q2 2026.
- How has Agios Pharmaceuticals's gross margin changed year-over-year?
- Agios Pharmaceuticals's gross margin increased by 4.3% year-over-year, from 88.2% to 92%.
- What is the long-term trend for Agios Pharmaceuticals's gross margin?
- Over 4 years (2020 to 2025), Agios Pharmaceuticals's gross margin has grown at a -2.7% compound annual growth rate (CAGR), from 98.6% to 88.3%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Agios Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude